Vaccines R&D-2017

United Scientific Group (USG) successfully completed First International Conference on Vaccines Research and Development, in Baltimore, MD, USA during November 02-04, 2015 (Vaccines R&D-2015) and Second International Conference on Vaccines Research and Development in Cartagena, Colombia during and November 10-12, 2016 (Vaccines R&D-2016).

With the enthusiasm and prodigious success of two annual conferences, USG are proudly announcing the Third International Conference on Vaccines Research and Development at Washington D.C, USA during November 13-15, 2017 (Vaccines R&D-2017).


The organizing committee is confident that participants will benefit from the high value scientific program and welcome all the researchers and experts to join us for these 3 days of stimulating discussions, knowledge sharing and networking event.

Speaker and Presenter Information

Jay A Berzofsky

Chief, Vaccine Branch, Center for Cancer Research, National Cancer Institute, USA

Stephen L. Hoffman

Chief Executive and Scientific Officer, Sanaria Inc., USA

Manuel Elkin Patarroyo M

Director, Fundacion Instituto de Inmunologia de Colombia

Odile Leroy

Executive Director, European Vaccine Initiative, Germany

Pierre A. MORGON

Chief Executive Officer, MRGN Advisors, Switzerland

Suresh Jadhav

Executive Director, Serum Institute of India Pvt. Ltd, India

Michael G. Hanna

Founder and Chief Executive Officer, Vaccinogen, Inc., USA

Marc Van Regenmortel

University of Strasbourg, France

Expected Number of Attendees


This event has no exhibitor/sponsor opportunities

Mon-Wed, Nov 13-15, 2017, 9:00am - 6:00pm


Early Bird Registration:  $349.00

Sheraton Reston Hotel
11810 Sunrise Valley Dr
Reston, VA 20191
Get directions

Click here to visit event website

United Scientific Group

Contact Event Organizer

Return to search results